SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-009634
Filing Date
2018-12-07
Accepted
2018-12-07 16:06:41
Documents
54
Period of Report
2018-10-31

Document Format Files

Seq Description Document Type Size
1 10-Q bpmx-20181031x10q.htm 10-Q 1696211
2 EX-4.1 bpmx-20181031ex4146fa4ab.htm EX-4.1 170701
3 EX-31.1 bpmx-20181031ex3113fbbf8.htm EX-31.1 19352
4 EX-31.2 bpmx-20181031ex312d2b6e9.htm EX-31.2 19275
5 EX-32.1 bpmx-20181031ex321c53792.htm EX-32.1 11541
  Complete submission text file 0001558370-18-009634.txt   6114669

Data Files

Seq Description Document Type Size
6 EX-101.INS bpmx-20181031.xml EX-101.INS 1262102
7 EX-101.SCH bpmx-20181031.xsd EX-101.SCH 39079
8 EX-101.CAL bpmx-20181031_cal.xml EX-101.CAL 35827
9 EX-101.DEF bpmx-20181031_def.xml EX-101.DEF 159152
10 EX-101.LAB bpmx-20181031_lab.xml EX-101.LAB 333732
11 EX-101.PRE bpmx-20181031_pre.xml EX-101.PRE 275191
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 001-37411 | Film No.: 181223529
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1